Clinical Assessment of a Massed Practice Therapy Device
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cerebrovascular Accident
- Sponsor
- Kinetic Muscles
- Enrollment
- 78
- Locations
- 2
- Primary Endpoint
- Wolf Motor Function Test
- Status
- Completed
- Last Updated
- 13 years ago
Overview
Brief Summary
The primary aim of this study is to investigate the effectiveness of the use of a robotic hand therapy device in the home environment. We hypothesize that the therapy group will improve hand function more than a customary and usual care group.
Detailed Description
Many stroke survivors have significant limitations of upper extremity function which impacts many important activities such as eating, dressing and personal care. Studies show that to be effective in increasing functional independence, therapy must involve active participation of the patient and repetitive training. Robotic therapy offers a means of transferring some of this essential, but time consuming, therapy into the home. Seventy subjects (3 to 12 months post stroke)are being randomized to a control group that utilizes an innovative robotic hand therapy device in the home for three months or a control group that receives no device treatment. Clinical motor function and quality of life measures will compare the groups before intervention, immediately after, and 3 months later. The control group will receive device treatment for 3 months following their final evaluation. The results will provide valuable data on the ability of monitored home therapy to provide effective treatment. This project has the potential to increase the availability of effective rehabilitation techniques to patients with stroke.
Investigators
James Koeneman
Chief Science Officer
Kinetic Muscles
Eligibility Criteria
Inclusion Criteria
- •3 to 24 months post stroke
- •Able to extend wrist and fingers at least 10 degrees
- •Functional hearing and vision
- •Able to follow instructions
- •Lives at home, not institution
- •Stable medications for 3 months
Exclusion Criteria
- •Excessive cognitive impairments
- •Taking/Receiving medicines/shots to make arm/hand less stiff
- •Severe pain in the impaired arm
- •Stroke was more than 24 months ago
Outcomes
Primary Outcomes
Wolf Motor Function Test
Time Frame: Initial, 6 wks, 12 wks, 16 wks, 52 wks
Secondary Outcomes
- Compliance with recommended use(6 wks, 12 wks)
- Fugl-Meyer Test(Initial, 6 wks, 12 wks, 16 wks, 52 wks)
- Stoke Impact Scale(Initial, 6 wks, 12 wks, 16 wks, 52 wks)